Pfizer Korea sponsors symposia on Detrusitol SR

Published: 2004-10-18 06:56:00

Updated: 2004-10-18 06:56:00

Pfizer Korea said it has sponsored its launching symposium concerning Detrusitol (L-tolterodine tartrate) SR using a double-capsule DDS formulation, which is used to relieve urinary difficulties, including frequent urination and inability to control urination. Tolerodine is in a class of medicati...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK